Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Allergan obtains rights for Ameluz in Spain

April 2, 2012

Shionogi and OncoTherapy Science expand licensing agreement

April 2, 2012

Optimer and Astellas enter commercialization agreement for fidaxomicin tablets

March 30, 2012

Pfizer and Astellas amend Lipitor licensing agreement

March 30, 2012

Toray and Taiho discontinue codevelopment of beta3-adrenoceptor agonist

March 30, 2012

Abide Therapeutics and Scynexis announce collaboration

March 30, 2012

JDRF and iCo Therapeutics join to support iDEAL trial

March 29, 2012

BioSeek and Merck Serono extend BioMAP collaboration

March 29, 2012

NGM and Daiichi Sankyo to collaborate on novel diabetes therapies

March 29, 2012

Lee's Pharmaceutical licenses RegeneRx candidates in China, Hong Kong and Macau

March 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...